Press Release

Institut Pasteur Korea to Foster New and Young Bio Startups

-2017 Bio Core Facility Project supported by Ministry of Science and ICT

Pangyo, Gyeonggi, 28 Aug, 2017 | Institut Pasteur Korea (IPK, CEO: Dr. Wang-Shick Ryu) announce it will nurture high-growth, promising Korean bio startups through the 2017 Bio Core Facility Project. For 5 weeks, from 25 Aug to 28 Sep, bio venture firms can apply for the 2017 Bio Core Facility Project.

Supported by Ministry of Science and ICT, the 2017 Bio Core Facility Project, is intended to accelerate Korean bio venture growth and promote its industrialization. The project will help young bio startups, less than three years, survive and grow during the startup period when they are the most vulnerable. A total of five startups will be selected. The chosen startups will each receive a 200 million KRW yearly re-search. Office and laboratory space will be provided at the IPK campus for three years rent free and all startups will have access to IPK’s technology platforms as well as training and mentorship.

IPK will have a briefing session on 31 Aug at the IPK auditorium. For more information on the project and the briefing session, see below:

Time: 14:00 PM ~, 31 Aug, 2017
Venue: 1st floor Auditorium at Institut Pasteur Korea
          (16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi)
Contact: Research Technology Management team (031-8018-8031~2 | Website: For more information on the Briefing Session information
             For more information on the Official Announcement

#  #  #  #  #  #

About Institut Pasteur Korea
Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and an economic growth engine that contributes to Korea's scientific intellectual and technical resources. IPK has four core missions of public interest; 1) Research, combining front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases, 2) Education, offering a wide range of programming to nurture the development of the next generation of scientists and health professionals, 3) Public Health, working in collaboration with national and international health authorities, and 4) Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
IPK is a member of the Institut Pasteur International Network (Network). As a hub institution, IPK plays a key role in the Network, serving as a bridge between Korea and global bio-pharma science, expanding Korea's R&D base collaborative research projects with global alliances
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science, ICT and Future Planning (MSIP). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).